Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of immunotherapies with MDM2 inhibitors

Combination of immunotherapies with MDM2 inhibitors

US Patent 12268665 · Granted Apr 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors2025
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors2025
Storage shed2025
Storage box2025
Method and compositions for predicting anti-cancer efficacy of compounds targeti2025
Method and compositions for predicting anti-cancer efficacy of compounds targeti2025
Method and compositions for predicting anti-cancer efficacy of compounds targeti2025
Storage shed2025